Provided by Tiger Trade Technology Pte. Ltd.

Bioventus Inc.

13.67
+0.02000.15%
Post-market: 13.990.3200+2.34%19:30 EDT
Volume:642.89K
Turnover:8.81M
Market Cap:1.15B
PE:17.48
High:13.94
Open:13.69
Low:13.50
Close:13.65
52wk High:15.89
52wk Low:6.26
Shares:84.09M
Float Shares:33.47M
Volume Ratio:1.30
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7821
EPS(LYR):0.3300
ROE:25.68%
ROA:5.49%
PB:5.04
PE(LYR):41.42

Loading ...

Bioventus Inc - Sees 2026 Adj EPS $0.75-$0.79, up $0.02 From Prior Guidance

THOMSON REUTERS
·
May 06

Bioventus Q1 Adjusted Ebitda USD 23.9 Million

THOMSON REUTERS
·
May 06

Bioventus Inc: Reaffirms Revenue Guidance for 2026

THOMSON REUTERS
·
May 06

Bioventus Q1 Adjusted EPS USD 0.15 VS. Ibes Estimate USD 0.1

THOMSON REUTERS
·
May 06

Press Release: Bioventus Reports First Quarter Financial Results

Dow Jones
·
May 06

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 06

Top News Today: Stocks Rise, Oil Falls, as War Restart Fears Subside

Dow Jones
·
May 06

Bioventus Inc expected to post earnings of 10 cents a share - Earnings Preview

Reuters
·
May 04

TELA Bio Inc - Prelim Q1 2026 Revenue Approx $19.0 Mln Versus Guidance of $18.5 Mln

THOMSON REUTERS
·
May 01

TELA Bio Inc - Joseph Capper to Be Nominated as Director and Expected to Serve as Chair

THOMSON REUTERS
·
May 01

TELA Bio Inc - Chairman Doug Evans, Kurt Azarbarzin, Vince Burgess, Federica O’brien to Depart Board

THOMSON REUTERS
·
May 01

Bioventus to report fiscal Q1 results, host conference call

Reuters
·
Apr 29

Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026

GlobeNewswire
·
Apr 29

Bioventus announces annual shareholder meeting

Reuters
·
Apr 22

Bravura Issues 1.6 Million Unquoted Options Under Employee Incentive Plan

TIPRANKS
·
Apr 22

Bravura Solutions Flags Conversion of Unquoted Equity Securities

TIPRANKS
·
Apr 02

Bravura Solutions Reshapes Governance Team With New Joint Company Secretaries

TIPRANKS
·
Apr 02

Bioventus initiated with an Outperform at CJS Securities

TIPRANKS
·
Mar 27

Bioventus Inc. publishes corporate presentation on musculoskeletal pain and surgical solutions portfolio with USD 568 million 2025 revenue

Reuters
·
Mar 17

Bravura Resets CEO Sign-On Option Price to Reflect Market Levels

TIPRANKS
·
Mar 16